Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?

Elie Cousin,Emmanuel Oger,Jean-Hugues Dalle,Yves Bertrand,Sophie Pertuisel,Cécile Pochon,Claire Galambrun,Pauline Simon,Bénédicte Bruno,Catherine Paillard,Pascale Schneider,Pierre Rohrlich,Regis Peffault de la Tour,Claire Freycon,Jean François Eliaou,G Semana,Philippe Jonveaux,Séverine Drunat,Pierre Bordigoni,Virginie Gandemer

Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?

2020

AbstractRelapse of acute myeloblastic leukemia (AML) after first allogenic hematopoietic stem-cell transplantation (allo-HSCT) is a fatal complication. Sixty-five children transplanted for AML were...

Keywords:

Haematopoiesis
Acute myeloblastic leukemia
Internal medicine
Diabetes mellitus
Transplantation
Medicine
Complication
Immunotherapy
Oncology
Chimera (genetics)
Pathology
Childhood Acute Myeloblastic Leukemia
post transplant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations